Glyconex MV 1mg/500mg/0.2mg Tablet ER
Marketer
Norlis Life Sciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyconex MV 1mg/500mg/0.2mg Tablet ER
Diabex Trio 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Diabex Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor; lifestyle adjustments are vital for diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (rapid-acting glucose sources). Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function as advised by your doctor.
Uses of Glyconex MV 1mg/500mg/0.2mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glyconex MV 1mg/500mg/0.2mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Glyconex MV 1mg/500mg/0.2mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
Common Side effects of Glyconex MV 1mg/500mg/0.2mg Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyconex MV 1mg/500mg/0.2mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glyconex MV 1mg/500mg/0.2mg Extended-Release tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
How Glyconex MV 1mg/500mg/0.2mg Tablet ER works:
Extended-release Glyconex MV tablets (1mg/500mg/0.2mg) combine three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glyconex MV 1mg/500mg/0.2mg Tablet ER poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glyconex MV tablet (1mg/500mg/0.2mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glyconex MV tablet (1mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glyconex MV 1mg/500mg/0.2mg Extended-Release tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Moreover, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glyconex MV 1mg/500mg/0.2mg Extended-Release Tablets. Dosage modification may be necessary. Physician consultation is advised. A low initial dose of Glyconex MV 1mg/500mg/0.2mg Extended-Release Tablets is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Glyconex MV 1mg/500mg/0.2mg Tablet ER :
Should you forget to take a Glyconex MV 1mg/500mg/0.2mg Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glyconex MV 1mg/500mg/0.2mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently